WallStSmart
INVA

Innoviva Inc

NASDAQ: INVA · HEALTHCARE · BIOTECHNOLOGY

$22.99
-0.26% today

Updated 2026-04-30

Market cap
$1.71B
P/E ratio
6.98
P/S ratio
4.15x
EPS (TTM)
$3.30
Dividend yield
52W range
$17 – $25
Volume
0.7M

Innoviva Inc (INVA) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
3 of 8
Last 8 quarters
Avg EPS surprise
+12.5%
Last 4 quarters
Revenue YoY growth
+28.6%
Most recent quarter
EPS YoY growth
+647.7%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+4.3%
Last 3 reports
Positive reaction rate
67%
2 of 3 quarters
Largest single-day move
+13.4%
2025-11-05
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-04$1.94+238.7%$22.30$22.18-0.5%
2025-11-05$0.38-3.9%$18.15$20.58+13.4%
2025-08-06$0.77+54.0%$18.44$18.46+0.1%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$0.57$1.94+238.7%$118.05M+28.6%
2025-09-30$0.40$0.38-3.9%$107.80M+20.4%
2025-06-30$0.50$0.77+54.0%$100.28M-3.0%
2025-03-31$0.33$-0.74-325.1%$88.63M+14.4%
2024-12-31$0.41$0.26-36.6%$91.81M+7.0%
2024-09-30$0.27$0.12-55.6%$89.51M+33.1%
2024-06-30$0.24$-0.55-329.2%$103.35M+27.6%
2024-03-31$0.17$0.46+170.6%$77.50M
2023-12-31$0.23$0.76+230.4%$85.84M
2023-09-30$0.27$0.98+263.0%$67.26M
2023-06-30$0.26$0.02-92.3%$80.99M

Frequently asked questions

Has Innoviva Inc beaten earnings estimates?
Innoviva Inc has beaten Wall Street EPS estimates in 3 of its last 8 quarterly reports, with an average EPS surprise of +12.5% over the last 4 quarters.
How does INVA stock react to earnings?
INVA stock has moved an average of +4.3% in the trading day following earnings over its last 3 reports, with positive reactions in 67% of those quarters.
What is Innoviva Inc's revenue growth rate?
Innoviva Inc reported year-over-year revenue growth of +28.6% in its most recent quarter, with EPS growing +647.7% year-over-year.